5-ethoxy-benzothiazol-2-ylamine → HCID 86611016, Verbindung
Reaktionsgleichung
[CH3:1][C:2]1([CH3:15])[O:11][C:10]2[C:5](=[CH:6][C:7]([C:12]#[N:13])=[CH:8][CH:9]=2)[CH:4]2[O:14][CH:3]12.[CH2:16]([O:18][C:19]1[CH:20]=[CH:21][C:22]2[S:26][C:25]([NH2:27])=[N:24][C:23]=2[CH:28]=1)[CH3:17]>>[CH2:16]([O:18][C:19]1[CH:20]=[CH:21][C:22]2[S:26][C:25]([NH:27][CH:4]3[C:5]4[C:10](=[CH:9][CH:8]=[C:7]([C:12]#[N:13])[CH:6]=4)[O:11][C:2]([CH3:15])([CH3:1])[CH:3]3[OH:14])=[N:24][C:23]=2[CH:28]=1)[CH3:17]Komponenten
3
Versuchsvorschrift
Following the procedure in Example 1, using (±)-2,2-dimethyl-1a,7b-dihydro-2H-1,3-dioxa-cyclopropa[a]naphthalene-6-carbonitrile and 5-ethoxy-benzothiazol-2-ylamine as starting material, the title compound was prepared as a white solid.
Quellen und Nachweise
- ORD-Eintrag
- ord-4739ccf666674966a0aa406fda63c42a
- Quelldatensatz
- uspto-grants-2010_10
- Patentnummer
- US07812183B2
Notizen zur Reaktion
Wird geladen…